Deep vein thrombosis - Clinical trials 

  • Clinical trials

Clinical trials for Deep vein thrombosis

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Deep vein thrombosis. For all clinical trials, go to clinical trials search

This list shows clinical trials for Deep vein thrombosis

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Deep vein thrombosis
Title Recruitment status Location
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). Recruiting United Kingdom
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism Recruiting United Kingdom
A RCT to Establish the Effectiveness of Intermittent Pneumatic Compression to Prevent Post Stroke DVT Recruiting United Kingdom
A randomised trial to establish the effectiveness of intermittent pneumatic compression sleeves (applied to the legs) to prevent post stroke deep vein thrombosis (DVT) Recruiting United Kingdom
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism Recruiting United Kingdom
Anticoagulation of Calf Thrombosis (ACT): A Pilot Feasibility Study Recruiting United Kingdom
A Phase 3, Randomized, Double-blind, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Safety and Efficacy of Apixaban in Subjects Undergoing Elective Total Hip Replacement Surgery + Pharmacogenetics Blood Sample Amendment 01 (Version 1.0 - dated 27-Nov-2006) Revised Protocol 01, incorporating Protocol Amendment 02 and Admin Letter 01 (Version 3.0, dated 21-Jun-07) Protocol Amendment 03 (Version 1.0 - dated 29-Apr-08) Not Recruiting United Kingdom
A phase III, randomised, multicenter, double-blind, parallel-group, active controlled study to evaluate the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for the secondary prevention of venous thromboembolism. RE-MEDY - RE-MEDY Not Recruiting United Kingdom
Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-Blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement Not recruiting United Kingdom
A phase III, randomised, multicenter, double-blind, parallel-group, active controlled study to evaluate the efficacy and safety of oral dabigatran etexilate 150 mg bid compared to warfarin INR 2.0-3.0 for the secondary prevention of venous thromboembolism RE-MEDY Secondary VTE prevention - RE-MEDY Not Recruiting United Kingdom
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member